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ABSTRACT
Platelet-rich plasma (PRP) is a new application of tissue engineering and a developing area for clinicians and
researchers. It is a storage vehicle of growth factors (GFs) such as platelet-derived growth factor (PDGF)-
AA, -BB, -AB; transforming growth factor (TGF)-b1 and -2; platelet-derived epidermal growth factor
(PDEGF); platelet-derived angiogenesis factor (PDAF); insulin growth factor-1 (IGF-1); and platelet factor-
4 (PF-4), which are known to influence bone regeneration. However, animal and clinical studies reveal
different results with the use of PRP and its effect on bone healing. This could be due to the differences
between species, that is, differences between species in GF concentrations or variation in presence of GFs
between the various PRPs. In this study, rat bone marrow cells were cultured in PRP-coated wells or in
uncoated wells for 16 days in osteogenic medium, and analyzed on cell growth (DNA content) and cell
differentiation (alkaline phosphatase [ALP] activity, calcium content, scanning electron microscopy, and
QPCR). The concentrations of TGF-b1, PDGF-AA, PDGF-AB, and PDGF-BB in rat, goat, and human PRP
were subsequently determined. The results showed that PRP stimulated initial cell growth and had no effect
on ALP activity. The calcium measurements showed a significant increase in calcium at days 8, 12, and 16.
The real-time PCR results showed that PRP upregulated osteocalcin at day 1 and collagen type I at day 8.
Overall, the immunoassays revealed that human PRP contained higher concentrations of growth factors per
platelet compared to rat and goat PRP. Goat PRP showed higher concentrations of growth factors per
platelet as compared to rat PRP except for PDGF-BB, which had a higher concentration in rat PRP. TGF-b1
was themost abundant growth factor in all 3 PRPs. On the basis of our results, we conclude that platelet-rich
plasma contains osteo-inductive growth factors, which are probably species related. However, we cannot
generalize the results because of large intraspecies variations. Further, we conclude that rat PRP gel sti-
mulates initial growth and differentiation of rat bone marrow cells in vitro.
INTRODUCTION
AUTOLOGOUS BONE OR BONE DERIVATIVES and substitutesfor jaw and periodontal reconstruction have significant
limitations in terms of availability, morbidity, efficacy,
immunologic reaction, and disease transmission. Therefore,
tissue engineering is an alternative approach, which in-
cludes, among others, the use of a synthetic material for the
delivery of osteogenic (osteoinductive) morphogens.
Platelet-rich plasma (PRP) as a storage vehicle of growth
factors (GFs) is a new application of tissue engineering and a
developing area for clinicians and researchers. The GFs, such
asplatelet-derivedgrowthfactor (PDGF[AA,BB,AB]), trans-
forming growth factor-b1 and -b2, platelet-derived epidermal
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growth factor (PDEGF), platelet-derived angiogenesis factor
(PDAF), insulin growth factor-1 (IGF-1), and platelet factor-4
(PF-4) are known to influence bone regeneration. In addition,
some authors have reported the presence of basic fibroblast
growth factor (bFGF), epithelial cell growth factor (ECGF),
interleukin-1 (cytokine), and osteonectin (major protein in
mineralized bone) in the a-granules of the platelets.1–4 All of
this implies that platelet concentrates might influence bone
formation through a variety of pathways.
The effects of PRP on osteoblast lineage have been con-
firmed by a few in vitro studies. Weibrich et al.5 observed
mitogenic effects of PRP on osteoblast-like cells. Annun-
ziata et al.6 and Lucarelli et al.7 showed an increase in
growth and differentiation of PRP-treated periodontal liga-
ment cells and stromal stem cells as indicated by alkaline
phosphatase (ALP) activity and collagen type I gene ex-
pression. Additional studies revealed that PRP stimulated
the mitogenic response of bone cells derived from human
trabecular8 and rat bone marrow.9 Yet, it is still unknown
whether the stimulatory effects of PRP is related to the GFs
present or to other microparticles from the cytoplasm or cell
membrane that are released from activated platelets.8
The action mechanism of GFs is very complex, because
each GF may have a different effect on the signal trans-
duction of bone matrix mineralization. GFs may also in-
teract with each other and consequently may form a cascade
of different signal proteins with multiple pathways, which
will ultimately lead to activation of gene expression fol-
lowed by protein production. This specific characteristic of
PRP, having multiple GFs, acting on multiple pathways,
distinguishes PRP from single recombinant GFs that focus
on a single signal transduction pathway.10,11
However, the number of in vitro studies is very limited
and additional questions needs to be answered. For example,
animal and clinical studies reveal different results with the
use of PRP and its effect on bone healing. Some researchers
reported an additional effect on bone regeneration by using
PRP in combination with bone grafts;12,13 others revealed no
differences.14,15 This could be due to the differences be-
tween species, that is, differences in GF concentrations be-
tween species or variation in the presence of GFs between
the various PRPs.
Therefore, the aim of this study was to examine the pre-
sence and the concentrations of GFs in rat, goat, and human
PRP. We examined the effect of rat PRP gel on rat bone
marrow cells.
MATERIALS AND METHODS
PRP preparation
Rat PRP was obtained by drawing the whole blood of
4 male Wistar rats via cardiac puncture into tubes containing
3.8% sodium citrate. PRP was obtained from this anticoa-
gulated blood after centrifugation at 800 rpm for 15min at
258C. Three milliliters of blood resulted in 150 mL of PRP.
The platelets present in the whole blood and in PRP were
counted automatically using a hematology analyzer. The
concentration of platelets obtained in the PRP was 3 times
higher than the baseline. This PRP was used to obtain a
PRP gel. The platelet concentrate was activated with a 10%
calcium chloride solution and 300 IU of bovine thrombin.
One hundred and fifty microliters of PRP was mixed with
25 mL of thrombin (300 IU) (FibriquikTM Thrombin, Bio-
Merieux, Durham, NC) together with 25 mL of 10% CaCl2.
Goat PRP and human PRP (1 patient) were obtained from
the Sanquin Bloodbank, Nijmegen, Regio Zuid-oost. The
PRP fraction was obtained from venous blood of 1 goat. For
this reason, 250 cm3 of blood was drawn and centrifuged at a
transfusion laboratory (Sanquin, Nijmegen, Netherlands) in
various cycles (Clemmons et al., 1983). Finally, 10–15mL
of PRP suspension was obtained. The platelet concentration
was also counted (platelet count exceeding 1200106/mL).
Quantitative sandwich enzyme immunoassay
A quantitative sandwich enzyme immunoassay (Quanti-
kine, R&D Systems Europe Ltd., Abingdon, UK) was used
for examining the amount of TGF-b1, PDGF-AA, PDGF-
AB, and PDGF-BB in rat, goat, and human PRP. The sam-
ples were activated by adding 0.1mL of 2.5 N acetic acid/
10M urea to 0.1mL of plasma. After 10min of incubation at
room temperature, the samples were neutralized by adding
0.1mL 2.7 N NaOH/1M N,2-hydroxyethylpiperazine-N 0-2-
ethanesulfonic acid (HEPES). The immunoassays were
performed following the manufacturer’s instructions.
Cell isolation
Rat bone marrow (RBM) cells were isolated and cultured
using the method described by Maniatopoulos et al.16 Fe-
mora of male Wistar rats were washed in culture medium
a-minimum essential medium (a-MEM, Gibco BRL, Life
Technologies B.V. Breda, The Netherlands) with 0.5mg/mL
of gentamicin and 3 mg/mL of Fungizone (Sigma-Aldrich,
St. Louis, MO). Epiphyses were cut off and diaphyses flu-
shed out with 15mL of osteogenic culture medium a-MEM,
supplemented with 10% fetal calf serum (FCS, Gibco BRL,
Life Technologies B.V. Breda, The Netherlands), 50 mg/mL
of ascorbic acid, 50 mg/mL of gentamicin, 10mM sodium
b-glycerophosphate, and 10–8 M dexamethasone (Sigma-
Aldrich). The cells were incubated in a humidified atmo-
sphere of 95% air, 5% CO2 at 378C for 7 days. The medium
was changed every 2 or 3 days.
Cell seeding
After 7 days of primary culture in osteogenic medium,
the pre-osteoblast-like cells were harvested and seeded in
24-well plates at a concentration of 10,000 cells/well. The
tissue culture polystyrene (TCPS) wells were first precoated
with an PRP gel (150 mL of PRP mixed with 25 mL of
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thrombin (300 IU) and mixed with 25 mL of 10% CaCl2 per
well) or left uncoated. Cells were cultured for 16 days in the
presence of osteogenic medium and incubated in a humi-
dified atmosphere of 95% air, 5% CO2 at 378C. The medium
was changed every 2 or 3 days.
DNA analysis
After 2, 4, 8, and 12 days samples were used for DNA
analysis. Medium was removed and cell layers were washed
twice with phosphate-buffered saline (PBS). One milliliter
of MilliQ was added to each sample. The samples were
frozen and thawed repeatedly. DNA standard curve was
made with l DNA. One hundred microliters of sample or
standard was added to 100 mL of Picogreen working solution
(Molecular Probes, Leiden, Netherlands) and the samples
were incubated for 10min at room temperature in the dark.
After incubation, DNA was measured using a fluorescence
microplate reader (Bio-Tek instruments, Abcoude, Nether-
lands) with excitation filter 365 nm and emission filter
450 nm. The same samples were also used for the ALP ac-
tivity assay.
ALP activity
ALP activity was measured at days 4, 8, and 12. For the
assay (Sigma-Aldrich), 96-well plates were used. Eighty
microliters of sample and 20 mL of buffer solution (5mM
MgCl2, 0.5M 2-amino-2-methyl-1-propanol) were added to
the wells. Subsequently, 100 mL of substrate solution (5mM
p-nitrophenylphosphate) was added to the wells and the
plate was incubated for 1 h at 378C. The reaction was stop-
ped by adding 100 mL of stop solution (0.3M NaOH). For
the standard curve, serial dilutions of 4-nitrophenol were
added to final concentrations of 0–25 nM. The plate was
read in an enzyme-linked immunosorbent assay (ELISA)
reader (Bio-Tek instruments, Abcoude, Netherlands) at
405 nm.
Calcium content
Calcium content in the samples was measured by the
ortho-cresolphthalein complexone (OCPC) method (Sigma-
Aldrich). Calcium content was examined at 8, 12, and 16
days of incubation. Cell layers were washed twice in PBS.
Five hundred microliters of 0.5 N acetic acid was added to
the wells and the samples were incubated overnight. Sam-
ples were frozen at 208C until use.
OCPC solution was prepared as follows: Eighty milli-
grams of OCPC was added to 75mL of demineralized H2O
with 0.5mL of 1M KOH, 0.5mL of 0.5 N acetic acid. To
prepare sample solution, 5mL of OCPC solution was added
to 5mL of 14.8M ethanolamine/boric acid buffer (pH 11),
2mL of 8-hydroxyquinoline (5 g in 100mL of 95% ethanol),
and 88mL of demineralized water. Three hundred micro-
liters of sample solution was added to 10 mL of sample. To
generate a standard curve, serial dilutions of CaCl2 were
made (1–200 mg/mL). The plate was incubated at room
temperature for 10min and then read at 575 nm.
RNA isolation
RNA was isolated from the cells with the aid of a RNA
isolation kit (RNeasy kit, QIAGEN, Venlo, Netherlands). The
cells were then disrupted by adding 350mL of RLT lysis
buffer. The samples were stored at 708C until use. The im-
munoassays were performed following the manufacturer’s
instructions.
The RNA obtained was quantified by adding 1 mL of
sample to 49 mL of RNase-free water and the absorbance was
measured in a spectrophotometer (Bio-Rad Laboratories,
Veenendaal, Netherlands) at 260 nm.
Reverse transcriptase polymerase
chain reaction (RT-PCR)
After isolation of the RNA, the RT reaction was per-
formed. One microgram of total RNA, 1 mL of 100 ng of
random primers, 1 mL of dNTP mix (10mM each), and
10 mL of distilled water was added to a nuclease-free mi-
crocentrifuge tube. The mixture was heated to 658C for
5min and quickly chilled on ice. The contents of the tube
were collected by brief centrifugation. Four microliters of
5first-strand buffer (250mM Tris-Cl, pH 8.3; 375mM
KCl; 15mMMgCl2) and 2 mL of 0.1M dithiothreitol (DDT)
were added. This was incubated at 258C for 10min, and
the contents of the tube were mixed gently and incubated
at 428C for 2min. Finally, 1 mL (200 U) of Superscript II
(Invitrogen, Breda, Netherlands) was added and the mixture
incubated at 428C for 50min. The reaction was inactivated
by heating the mixture at 708C for 15min. The obtained
cDNA was used as a template in the PCR.
Quantitative PCR
The cDNA from the RT reaction was used as a template in
PCR. To perform quantitative PCR, 4.5mL of RNase-free
water, 12.5mL of SYBR Green MasterMix (Eurogentec,
Liege, Belgium), 5mL of cDNA, 1.5mL of reverse primer, and
1.5mL of forward primer were added to a QRT-PCR 96-well
plate. This plate was sealed, and the Q-PCR run was per-
formed with the MyiQ Single-Color Real-Time Detection
System for quantification with SYBR Green and melting
curve analysis (Bio-Rad, Richmond, CA). DNA was PCR-
amplified under the following conditions: 2min at 508C and
10min at 958C, followed by 40 cycles of 15 s at 958C and
1min at 608C, with data collection in the last 30 s. The re-
ference household gene used to normalize the amount of
mRNA in the cultures was GAPDH (DCT ¼ CT,gene of interest
CT,GAPDH [1]). Gene expression was measured relative to the
gene expression of cultures on the relevant substrates (PRP
gel-coatedoruncoatedTCPS) thathadnot receivedantibodies,
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after day 1 of culture (DDCT ¼ DCT,sampleDCT,control [2]).
The-fold change in gene expression relative to the control was
calculated via 2DDCT (3).17
Statistical analysis
This study was performed using 2 separate runs of ex-
periments. In each run, samples were present in quadruple.
In the Results section, data of both runs are described but
only the first run is presented in the figures. Statistical
analysis was performed for each run by using an unpaired t-
test (GraphPad Software, San Diego, CA).
RESULTS
Presence and quantification of GFs in rat,
goat and human PRP
The concentrations of GFs—TGF-b1, PDGF-AA, PDGF-
BB, and PDGF-AB—in rat, goat, and human PRP were
examined. Rat PRP was prepared by 1 centrifugation step
and resulted in a 3-fold increase of platelets above baseline
(rat PRP¼ 3000106/mL). Human and goat PRP were
prepared in 2 centrifugation steps and resulted also in a
3-fold increase for goat and 6-fold increase for human in
platelets above baseline (goat and human PRP¼ 1200106/
mL). As shown in Table 1 and Fig. 1, various GFs were
tested and different concentrations of GFs were obtained in
rat, goat, and human PRP. For TGF-b1, 7.8 ng/mL was de-
tected in rat PRP, 53 ng/mL was detected in goat PRP, and
2.6 mg/mL was detected in human PRP. For PDGF-AA,
9.7 pg/mL was detected in rat PRP, 561 pg/mL was detected
in goat PRP, and 7.9 ng/mL was detected in human PRP. For
PDGF AB, 10 pg/mL was detected in rat PRP, 108 pg/mL
was detected in goat PRP, and 76.4 ng/mL was detected in
human PRP. For PDGF-BB, 590 pg/mL was detected in rat
PRP, 39 pg/mL was detected in goat PRP, and 66 ng/mL was
detected in human PRP.
Effect of rat PRP gel on rat bone marrow cells
The DNA results showed that PRP stimulated the initial
cell growth significantly at days 2 and 4 ( p< 0.05). A linear
growth curve for uncoated control samples was observed. In
contrast, the coated samples showed a linear growth from
day 2 to 4, a steady state from day 4 to 8, and a decrease in
DNA from day 8 to 12 (Fig. 2).
A negative effect of PRP on the ALP activity could be
observed at days 4, 8, and 12. The ALP activity of the
control samples showed an increase of activity from day 4 to
8 to 12 while the PRP-coated samples showed an ALP ac-
tivity at a constant low level (Fig. 3).
A significant increase in calcium content was found at days
8, 12, and 16 for the samples coatedwith PRP compared to the
uncoated samples ( p< 0.05). The uncoated samples showed
only a low amount of calcium at day 16 (Fig. 4).
Real-time PCRwas performed to get some additional data
about the gene expression of certain osteogenic markers.
The results showed that PRP downregulated ALP and bone
sialoprotein at days 1 and 8. It downregulated osteocalcin at
day 8 and downregulated collagen type I at day 1. However,
PRP upregulated osteocalcin at day 1 and upregulated col-
lagen type I at day 8 (Fig. 5).
TABLE 1. CONCENTRATIONS OF THE GFS TGF-b1,
PDGF-AA, -AB, AND -BB IN RAT, GOAT, AND HUMAN PRP
Growth
factor PRP Concentration
Concentration (pg/mL)/
p¼ 1000 * 106
TGF-b1 Rat 23.3 ng/mL 7767
Goat 63.5 ng/mL 52,917
Human 3.1mg/mL 2,580,000
PDGF-AA Rat 29.2 pg/mL 9.73
Goat 673.5 pg/mL 561
Human 9.5 ng/mL 7916
PDGF-AB Rat 30.2 pg/mL 10
Goat 129.2 pg/mL 108
Human 91.7 ng/mL 76,417
PDGF-BB Rat 1.77 ng/mL 590
Goat 47 pg/mL 39
Human 79.3 ng/mL 66,083
FIG. 1. Concentration of the GFs TGF-b1, PDGF-AA, -AB and
-BB in rat, goat, and human PRP.
FIG. 2. Cell growth of rat bone marrow cells cultured on PRP-
coated and noncoated wells (1st run).
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DISCUSSION
The results of our immunoassays revealed that human
PRP contained higher concentrations of GFs per platelet as
compared to rat and goat PRP. Goat PRP showed also higher
concentrations of GFs per platelet compared to rat PRP
except for PDGF-BB, which had a higher concentration in
rat PRP. TGF-b1 was the most abundant GF in all 3 PRPs.
As of yet no data are available about the differences among
rat, goat, and human PRP. Apart from animal studies with
successful outcomes for PRP, there are also contradictory
results in which no benefit of PRP was found.3,18 The pre-
sent results can probably explain why it is currently very
difficult to obtain a beneficial effect of PRP in experimental
animal studies. The PRP applied was always prepared from
blood of the experimental animals, while no data were
available about the amount of platelets that need to be used
in the studies. This could be species-related because of the
differences in concentrations of the GFs in PRPs obtained
from rat, goat, and human. Only a few studies have reported
on the synergistic effects of multiple GFs in a defective site.
There are still many questions to be answered before the
exact mechanism of the action of PRP can be fully ex-
plained.
According to Marx et al.,1 human PRP is an autologous
concentration of human platelets above baseline in a small
volume of plasma. Normal platelet counts in human blood
range between 150106/mL and 350106/mL with an aver-
age of about 200106/mL. A concentration of 1000106/mL
in a 5-mL volume of plasma could be the working definition
of human PRP. Platelet concentrations of less than 1000
106/mL were not reliable to enhance wound healing, whereas
higher concentrations did not show further enhancement
of wound healing.19 Weibrich et al.20 examined the platelet
concentration among different human donors and discovered
that the platelet concentration of the human PRP, prepared in
a blood bank, correlated with the platelet count in the donor
whole blood. They found also a significant influence of
gender on platelet concentration, but no influence of age. On
the other hand, Paques et al.21 demonstrated that the con-
centrations of the GFs present in human platelet lysates were
not related to donor origin. Regarding the required platelet
concentration for PRP efficiency, Haynesworth et al.22
showed that the proliferation and differentiation of adult
mesenchymal stem cells were directly related to the platelet
concentration. They showed a dose–response curve indicat-
ing that a sufficient cellular response to platelet concentra-
tions first began when a 4- to 5-fold increase over baseline
platelet numbers was achieved. Platelet concentrations ran-
ged from 800 to 1200106 platelets/mL have been proposed
to be effective by Weibrich et al. and Fennis et al.23,24
As most individuals have a baseline blood platelet count of
200 75106/mL, a platelet count of 1000106/mL as
FIG. 3. ALP activity of rat bone marrow cells cultured on PRP-
coated and noncoated wells (1st run).
FIG. 4. Calcium content of rat bone marrow cells cultured on
PRP-coated and noncoated wells (1st run).
FIG. 5. Relative quantity of mRNA (%) of ALP (alkaline
phosphatase), OCN (osteocalcin), ColI (collagen type I), and BSP
(bone sialoprotein). The so-called 2DDCT method was used to
evaluate the differences in gene expression between uncoated (PRP
min) and PRP-coated samples (PRP plus). All Ct values were
normalized to the CT values of the housekeeping gene GAPDH.
Second, the DCT values of PRP were normalized to the DCT values
of the control group, the uncoated samples. Finally, the 2DDCT
values of the control group were called 100% while the 2DDCT
values of the PRP-coated groups were multiplied by 100%.
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measured in a volume of 5mL plasma can be the ‘‘therapeutic
dose’’ of PRP.2,25 The PRP formulations that were used in
our study had a 3-fold increase for rat and goat and a 6-fold
increase for human PRP; that is, rat PRP had a concentration
of 3000106/mL (whole blood 1000106/mL), goat PRP
had a concentration of 1200106/mL (whole blood 400106/
mL) and human PRP had a concentration of 1200106/mL
(whole blood 200106/mL).
The present study revealed that PRP had a stimulating
effect on the initial cell growth and matrix mineralization of
rat bone marrow cells. This is in agreement with Lucarelli
et al.7 andWeibrich et al.,5 who also observed increased cell
growth and differentiation with osteoblast-like cells and
stromal cells. Soffer et al.26 observed in a study with fetal rat
calvarial cells that short-term exposure (24 h) of PRP to the
cells stimulated the growth and differentiation of these cells.
However, a long-term exposure resulted in a decrease in
both ALP activity and mineral formation. Choi et al.27 and
Arpornmaeklong et al.28 showed in their study that the via-
bility and proliferation of alveolar bone cells obtained from
mongrel dogs and rat bone marrow cells were suppressed by
high PRP concentrations, but were stimulated by low PRP
concentrations. Arpornmaeklong et al.28 observed also that
the cell differentiation of rat bone marrow cells was sup-
pressed with a high concentration of PRP. In the present
study, the well plates were coated with a PRP gel. Therefore,
the cells probably experienced a short-term exposure of
GFs. As known from other studies the life span of a platelet
in a wound and the period of direct influence of its GFs is
less than 5 days in in vivo situations.29 After the initial burst
of GFs, the platelets synthesize and secrete additional GFs
for the remaining days of their life span. However, it can be
questioned whether this same GF release pattern will occur
in an in vitro situation. Tsay et al.30 showed in their in vitro
study that PRP gels had a burst release of 80% of PDGF-AB
and 82% of TGF-b1 in the medium after 24 h and a sustained
release for another 14 days.
Additional studies revealed that PRP stimulated the mi-
togenic response of bone cells derived from human trabe-
cular8 and rat bone marrow.9 Yet, it is still unknown whether
the stimulatory effects of PRP is related to the GFs present or
to other microparticles from the cytoplasm or cell membrane
that are released from activated platelets.8 However, our
ELISA results and also Soffer et al.26 showed that appro-
priate amounts of GFs can be detected. Previous in vitro
studies with single GFs, such as TGF-b1, showed already
that concentrations of 5–10 ng/mL in rat bone marrow cell
cultures result in increased cell proliferation with no effect
on cell differentiation.31 Other authors reported that the
single GFs PDGF-AA and BB enhanced cell proliferation of
bone cells (10 ng/mL)10,32,33 Antibodies against PDGF ap-
peared to decrease the mitogenic activity of human bone
cells with PRP.8
Real-time PCR results showed a downregulation for the
ALP gene when PRP was used as the coating. This is in
keeping with our ALP activity results, which showed a de-
crease in activity with PRP, while more calcium content was
measured with PRP-coated samples. In accordance with the
calcium results, the PCR results showed an upregulation for
the genes osteocalcin (as a marker for the osteoblast phe-
notype) and collagen type I (as a marker for matrix miner-
alization).
The present study also contains some limitations. Rat PRP
was obtained from 6 rats and was used for rat bone marrow
cell culture and GF quantification, but the human and goat
PRP samples for GF quantification were taken from 1 pa-
tient or 1 animal. Therefore, we cannot generalize the results
obtained from GF quantification because of the large in-
traspecies variations.
CONCLUSION
On the basis of our results, we conclude that PRP contains
osteo-inductive GFs, which are probably species related.
However, we cannot generalize the results because of the
large intraspecies variations. Further, we conclude that rat
PRP gel stimulates the initial growth and differentiation of
rat bone marrow cells in vitro. Evidently, PRP has the po-
tential to be an osteoinductive factor for GF-based tissue
engineering.
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